North America Flu Vaccine Market by Manufacturers, Countries, Type and Application, Forecast to 2022

December 2017 | 122 pages | ID: NFEFC0DF62AEN
GlobalInfoResearch

Abstracts

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

Scope of the Report:

This report focuses on the Flu Vaccine in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers

• CSL
• GSK
• Sanofi Pasteur
• Mylan
• AstraZeneca
• Pfizer
• Johnson & Johnson

Market Segment by Countries, covering

• United States
• Canada
• Mexico

Market Segment by Type, covers

• Whole Virus Vaccines
• Split Virus Vaccines
• Subunit Vaccines
• Live Attenuated Virus Vaccines

Market Segment by Applications, can be divided into

• For Children (6 months to 3 years)
• For Adults and Children over 3 years

There are 15 Chapters to deeply display the North America Flu Vaccine market.

Chapter 1, to describe Flu Vaccine Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Flu Vaccine, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Flu Vaccine, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Flu Vaccine market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Flu Vaccine Research Findings and Conclusion, Appendix, methodology and data source

Contents

1 MARKET OVERVIEW

1.1 Flu Vaccine Introduction
1.2 Market Analysis by Type
  1.2.1 Whole Virus Vaccines
  1.2.2 Split Virus Vaccines
  1.2.3 Subunit Vaccines
  1.2.4 Live Attenuated Virus Vaccines
1.3 Market Analysis by Applications
  1.3.1 For Children (6 months to 3 years)
  1.3.2 For Adults and Children over 3 years
1.4 Market Analysis by Countries
  1.4.1 United States Status and Prospect (2012-2022)
  1.4.2 Mexico Status and Prospect (2012-2022)
  1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 CSL
  2.1.1 Profile
  2.1.2 Flu Vaccine Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 CSL Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.1.4 Business Overview
  2.1.5 CSL News
2.2 GSK
  2.2.1 Profile
  2.2.2 Flu Vaccine Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 GSK Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.2.4 Business Overview
  2.2.5 GSK News
2.3 Sanofi Pasteur
  2.3.1 Profile
  2.3.2 Flu Vaccine Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 Sanofi Pasteur Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.3.4 Business Overview
  2.3.5 Sanofi Pasteur News
2.4 Mylan
  2.4.1 Profile
  2.4.2 Flu Vaccine Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 Mylan Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.4.4 Business Overview
  2.4.5 Mylan News
2.5 AstraZeneca
  2.5.1 Profile
  2.5.2 Flu Vaccine Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 AstraZeneca Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.5.4 Business Overview
  2.5.5 AstraZeneca News
2.6 Pfizer
  2.6.1 Profile
  2.6.2 Flu Vaccine Type and Applications
    2.6.2.1 Type
    2.6.2.2 Type
  2.6.3 Pfizer Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.6.4 Business Overview
  2.6.5 Pfizer News
2.7 Johnson & Johnson
  2.7.1 Profile
  2.7.2 Flu Vaccine Type and Applications
    2.7.2.1 Type
    2.7.2.2 Type
  2.7.3 Johnson & Johnson Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.7.4 Business Overview
  2.7.5 Johnson & Johnson News

3 NORTH AMERICA FLU VACCINE MARKET COMPETITION, BY MANUFACTURER

3.1 North America Flu Vaccine Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Flu Vaccine Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Flu Vaccine Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Flu Vaccine Manufacturer Market Share
  3.4.2 Top 5 Flu Vaccine Manufacturer Market Share
3.5 Market Competition Trend

4 NORTH AMERICA FLU VACCINE MARKET ANALYSIS BY COUNTRIES

4.1 North America Flu Vaccine Sales Market Share by Countries
4.2 North America Flu Vaccine Sales by Countries (2012-2017)
4.3 North America Flu Vaccine Revenue (Value) by Countries (2012-2017)

5 NORTH AMERICA MARKET SEGMENTATION FLU VACCINE BY TYPE

5.1 North America Flu Vaccine Sales, Revenue and Market Share by Type (2012-2017)
  5.1.1 North America Flu Vaccine Sales and Market Share by Type (2012-2017)
  5.1.2 North America Flu Vaccine Revenue and Market Share by Type (2012-2017)
5.2 Whole Virus Vaccines Sales Growth and Price
  5.2.1 North America Whole Virus Vaccines Sales Growth (2012-2017)
  5.2.2 North America Whole Virus Vaccines Price (2012-2017)
5.3 Split Virus Vaccines Sales Growth and Price
  5.3.1 North America Split Virus Vaccines Sales Growth (2012-2017)
  5.3.2 North America Split Virus Vaccines Price (2012-2017)
5.4 Subunit Vaccines Sales Growth and Price
  5.4.1 North America Subunit Vaccines Sales Growth (2012-2017)
  5.4.2 North America Subunit Vaccines Price (2012-2017)
5.5 Live Attenuated Virus Vaccines Sales Growth and Price
  5.5.1 North America Live Attenuated Virus Vaccines Sales Growth (2012-2017)
  5.5.2 North America Live Attenuated Virus Vaccines Price (2012-2017)

6 NORTH AMERICA MARKET SEGMENTATION FLU VACCINE BY APPLICATION

6.1 North America Flu Vaccine Sales Market Share by Application (2012-2017)
6.2 For Children (6 months to 3 years) Sales Growth (2012-2017)
6.3 For Adults and Children over 3 years Sales Growth (2012-2017)

7 UNITED STATES FLU VACCINE SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

7.1 United States Flu Vaccine Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Flu Vaccine Sales and Market Share by Type
7.3 United States Flu Vaccine Sales by Application (2012-2017)
7.4 United States Flu Vaccine Sales, Revenue and Market Share by Manufacturer
  7.4.1 United States Flu Vaccine Sales and Market Share by Manufacturer
  7.4.2 United States Flu Vaccine Revenue and Market Share by Manufacturer
7.5 United States Flu Vaccine Export and Import (2012-2017)

8 CANADA FLU VACCINE SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

8.1 Canada Flu Vaccine Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Flu Vaccine Sales and Market Share by Type
8.3 Canada Flu Vaccine Sales by Application (2012-2017)
8.4 Canada Flu Vaccine Sales, Revenue and Market Share by Manufacturer
  8.4.1 Canada Flu Vaccine Sales and Market Share by Manufacturer
  8.4.2 Canada Flu Vaccine Revenue and Market Share by Manufacturer
8.5 Canada Flu Vaccine Export and Import (2012-2017)

9 MEXICO FLU VACCINE SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

9.1 Mexico Flu Vaccine Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Flu Vaccine Sales and Market Share by Type
9.3 Mexico Flu Vaccine Sales by Application (2012-2017)
9.4 Mexico Flu Vaccine Sales, Revenue and Market Share by Manufacturer
  9.4.1 Mexico Flu Vaccine Sales and Market Share by Manufacturer
  9.4.2 Mexico Flu Vaccine Revenue and Market Share by Manufacturer
9.5 Mexico Flu Vaccine Export and Import (2012-2017)

10 FLU VACCINE MARKET FORECAST (2017-2022)

10.1 North America Flu Vaccine Sales, Revenue and Growth Rate (2017-2022)
10.2 Flu Vaccine Market Forecast by Countries (2017-2022)
  10.2.1 United States Flu Vaccine Forecast (2017-2022)
  10.2.2 Canada Flu Vaccine Forecast (2017-2022)
  10.2.3 Mexico Flu Vaccine Forecast (2017-2022)
10.3 Flu Vaccine Market Forecast by Type (2017-2022)
10.4 Flu Vaccine Market Forecast by Application (2017-2022)

11 FLU VACCINE MANUFACTURING COST ANALYSIS

11.1 Flu Vaccine Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Flu Vaccine

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Flu Vaccine Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Flu Vaccine Major Manufacturers in 2016
12.4 Downstream Buyers

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Flu Vaccine Picture
Table Product Specifications of Flu Vaccine
Figure North America Sales Market Share of Flu Vaccine by Types in 2016
Table Types of Flu Vaccine
Figure Whole Virus Vaccines Picture
Table Major Manufacturers of Whole Virus Vaccines
Figure Split Virus Vaccines Picture
Table Major Manufacturers of Split Virus Vaccines
Figure Subunit Vaccines Picture
Table Major Manufacturers of Subunit Vaccines
Figure Live Attenuated Virus Vaccines Picture
Table Major Manufacturers of Live Attenuated Virus Vaccines
Table North America Flu Vaccine Sales Market Share by Applications in 2016
Table Applications of Flu Vaccine
Figure For Children (6 months to 3 years) Picture
Figure For Adults and Children over 3 years Picture
Figure United States Flu Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Flu Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Flu Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Table CSL Basic Information, Manufacturing Base and Competitors
Table CSL Flu Vaccine Type and Applications
Table CSL Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Flu Vaccine Type and Applications
Table GSK Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table Sanofi Pasteur Flu Vaccine Type and Applications
Table Sanofi Pasteur Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Flu Vaccine Type and Applications
Table Mylan Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Flu Vaccine Type and Applications
Table AstraZeneca Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Flu Vaccine Type and Applications
Table Pfizer Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Flu Vaccine Type and Applications
Table Johnson & Johnson Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America Flu Vaccine Sales by Manufacturer (2016-2017)
Figure North America Flu Vaccine Sales Market Share by Manufacturer in 2016
Figure North America Flu Vaccine Sales Market Share by Manufacturer in 2017
Table North America Flu Vaccine Revenue by Manufacturer (2016-2017)
Figure North America Flu Vaccine Revenue Market Share by Manufacturer in 2016
Figure North America Flu Vaccine Revenue Market Share by Manufacturer in 2017
Table North America Flu Vaccine Price by Manufacturers (2016-2017)
Figure Top 3 Flu Vaccine Manufacturer Market Share in 2016
Figure Top 3 Flu Vaccine Manufacturer Market Share in 2017
Figure Top 5 Flu Vaccine Manufacturer Market Share in 2016
Figure Top 5 Flu Vaccine Manufacturer Market Share in 2017
Figure North America Flu Vaccine Sales and Growth (2012-2017)
Table North America Flu Vaccine Sales by Countries (2012-2017)
Table North America Flu Vaccine Sales Market Share by Countries (2012-2017)
Figure North America 2012 Flu Vaccine Sales Market Share by Countries
Figure North America 2016 Flu Vaccine Sales Market Share by Countries
Figure North America Flu Vaccine Revenue and Growth (2012-2017)
Table North America Flu Vaccine Revenue by Countries (2012-2017)
Table North America Flu Vaccine Revenue Market Share by Countries (2012-2017)
Table North America 2012 Flu Vaccine Revenue Market Share by Countries
Table North America 2016 Flu Vaccine Revenue Market Share by Countries
Table North America Flu Vaccine Sales by Type (2012-2017)
Table North America Flu Vaccine Sales Share by Type (2012-2017)
Table North America Flu Vaccine Revenue by Type (2012-2017)
Table North America Flu Vaccine Revenue Share by Type (2012-2017)
Figure North America Whole Virus Vaccines Sales Growth (2012-2017)
Figure North America Whole Virus Vaccines Price (2012-2017)
Figure North America Split Virus Vaccines Sales Growth (2012-2017)
Figure North America Split Virus Vaccines Price (2012-2017)
Figure North America Subunit Vaccines Sales Growth (2012-2017)
Figure North America Subunit Vaccines Price (2012-2017)
Figure North America Live Attenuated Virus Vaccines Sales Growth (2012-2017)
Figure North America Live Attenuated Virus Vaccines Price (2012-2017)
Table North America Flu Vaccine Sales by Application (2012-2017)
Table North America Flu Vaccine Sales Share by Application (2012-2017)
Figure North America For Children (6 months to 3 years) Sales Growth (2012-2017)
Figure North America For Adults and Children over 3 years Sales Growth (2012-2017)
Figure United States Flu Vaccine Revenue and Growth (2012-2017)
Figure United States Flu Vaccine Sales and Growth (2012-2017)
Table United States Flu Vaccine Sales by Type (2012-2017)
Table United States Flu Vaccine Sales Market Share by Type (2012-2017)
Table United States Flu Vaccine Sales by Application (2012-2017)
Table United States Flu Vaccine Sales Market Share by Application (2012-2017)
Table United States Flu Vaccine Sales by Manufacturer (2016-2017)
Figure United States Flu Vaccine Sales Market Share by Manufacturer in 2016
Figure United States Flu Vaccine Sales Market Share by Manufacturer in 2017
Table United States Flu Vaccine Revenue by Manufacturer (2016-2017)
Figure United States Flu Vaccine Revenue Market Share by Manufacturer in 2016
Figure United States Flu Vaccine Revenue Market Share by Manufacturer in 2017
Table United States Flu Vaccine Export and Import (2012-2017)
Figure Canada Flu Vaccine Revenue and Growth (2012-2017)
Figure Canada Flu Vaccine Sales and Growth (2012-2017)
Table Canada Flu Vaccine Sales by Type (2012-2017)
Table Canada Flu Vaccine Sales Market Share by Type (2012-2017)
Table Canada Flu Vaccine Sales by Application (2012-2017)
Table Canada Flu Vaccine Sales Market Share by Application (2012-2017)
Table Canada Flu Vaccine Sales by Manufacturer (2016-2017)
Figure Canada Flu Vaccine Sales Market Share by Manufacturer in 2016
Figure Canada Flu Vaccine Sales Market Share by Manufacturer in 2017
Table Canada Flu Vaccine Revenue by Manufacturer (2016-2017)
Figure Canada Flu Vaccine Revenue Market Share by Manufacturer in 2016
Figure Canada Flu Vaccine Revenue Market Share by Manufacturer in 2017
Table Canada Flu Vaccine Export and Import (2012-2017)
Figure Mexico Flu Vaccine Revenue and Growth (2012-2017)
Figure Mexico Flu Vaccine Sales and Growth (2012-2017)
Table Mexico Flu Vaccine Sales by Type (2012-2017)
Table Mexico Flu Vaccine Sales Market Share by Type (2012-2017)
Table Mexico Flu Vaccine Sales by Application (2012-2017)
Table Mexico Flu Vaccine Sales Market Share by Application (2012-2017)
Table Mexico Flu Vaccine Sales by Manufacturer (2016-2017)
Figure Mexico Flu Vaccine Sales Market Share by Manufacturer in 2016
Figure Mexico Flu Vaccine Sales Market Share by Manufacturer in 2017
Table Mexico Flu Vaccine Revenue by Manufacturer (2016-2017)
Figure Mexico Flu Vaccine Revenue Market Share by Manufacturer in 2016
Figure Mexico Flu Vaccine Revenue Market Share by Manufacturer in 2017
Table Mexico Flu Vaccine Export and Import (2012-2017)
Figure North America Flu Vaccine Sales, Revenue and Growth Rate (2017-2022)
Table North America Flu Vaccine Sales Forecast by Countries (2017-2022)
Table North America Flu Vaccine Market Share Forecast by Countries (2017-2022)
Figure United States Flu Vaccine Sales Forecast (2017-2022)
Figure Canada Flu Vaccine Sales Forecast (2017-2022)
Figure Mexico Flu Vaccine Sales Forecast (2017-2022)
Table North America Flu Vaccine Sales Forecast by Type (2017-2022)
Table North America Flu Vaccine Market Share Forecast by Type (2017-2022)
Table North America Flu Vaccine Sales Forecast by Application (2017-2022)
Table North America Flu Vaccine Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Flu Vaccine
Figure Manufacturing Process Analysis of Flu Vaccine
Figure Flu Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Flu Vaccine Major Manufacturers in 2016
Table Major Buyers of Flu Vaccine
Table Distributors/Traders/ Dealers List